Articles
Volume 12 Supplement 1
Clinical Trials Methodology Conference 2011
Meeting abstracts
Clinical Trials Methodology Conference 2011
Bristol, UK
4-5 October 2011
Edited by Stephanie McAvoy and Emily Crowe
This conference was sponsored by the Network of Hubs for Trials Methodology Research
|
Invited speaker presentation
Adaptive designs: current status, future outlook Andy Grieve Trials 2011, 12(Suppl 1):A1 (13 December 2011) |
|
Oral presentation
Nigel Stallard Trials 2011, 12(Suppl 1):A2 (13 December 2011) |
|
Oral presentation
Matthew R Sydes, Nicholas D James, Malcolm D Mason, Noel W Clarke, Claire Amos, John Anderson, Johann de Bono, David P Dearnaley, John Dwyer, Gordana Jovic, Alastair Ritchie, Martin Russell, Karen Sanders, George Thalmann, Mahesh KB Parmar Trials 2011, 12(Suppl 1):A3 (13 December 2011) |
|
Oral presentation
Optimal design for multi-arm multi-stage clinical trials James MS Wason, Thomas Jaki Trials 2011, 12(Suppl 1):A4 (13 December 2011) |
|
Poster presentation
Model selection and sample size adaptation: HYPAZ trial Simon Bond, Adrian Mander, Duncan Jodrell, Joseph Cheryian Trials 2011, 12(Suppl 1):A5 (13 December 2011) |
|
Poster presentation
How Cancer Research UK is adapting to adaptive designs Julie Hearn, Nicola Keat, Kate Law, Rowena Sharpe Trials 2011, 12(Suppl 1):A6 (13 December 2011) |
|
Poster presentation
The importance of planning for a seamless transition in an adaptive phase II randomised trial Andrea Marshall, Janet A Dunn, Julie Fletcher, Helen B Higgins, Christopher J Poole Trials 2011, 12(Suppl 1):A7 (13 December 2011) |
|
Poster presentation
Nick Parsons, Tim Friede, Susan Todd, Nigel Stallard Trials 2011, 12(Suppl 1):A8 (13 December 2011) |
|
Invited speaker presentation
Stephen JW Evans Trials 2011, 12(Suppl 1):A9 (13 December 2011) |
|
Oral presentation
Elizabeth N Allen, Karen I Barnes, Adiel Mushi, Isolide Massawe, Sarah G Staedke, Ushma Mehta, Lasse S Vestergaard, Martha M Lemnge, Clare I Chandler Trials 2011, 12(Suppl 1):A10 (13 December 2011) |
|
Oral presentation
Anti-epileptic drug harms: issues for meta-analysis Catrin Smith, Arif Shukralla, Sarah Donegan, Karla Hemming, Graham A Powell, Paula Williamson, Anthony Marson Trials 2011, 12(Suppl 1):A11 (13 December 2011) |
|
Poster presentation
Victoria R Cornelius, Odile Sauzet, Salma Ayis, Joy Ross, Paul Farquhar-Smith, Ruth A Branford, John E Williams, Janet L Peacock Trials 2011, 12(Suppl 1):A12 (13 December 2011) |
|
Poster presentation
Barnaby C Reeves, Wendy Underwood, Heike Cappel-Porter, Sarah Baos, Chris A Rogers, Michael Arnott, Simon P Harding, Usha Chakravarthy, Alex E Foss Trials 2011, 12(Suppl 1):A13 (13 December 2011) |
|
Invited speaker presentation
Using biomarkers prospectively in adaptive clinical trials Donald A Berry Trials 2011, 12(Suppl 1):A14 (13 December 2011) |
|
Oral presentation
Athanasios Anastasiou, Emmanuel Ifeachor, John Zajicek Trials 2011, 12(Suppl 1):A15 (13 December 2011) |
|
Oral presentation
Kinga Malottki, Mousumi Biswas, Jon Deeks, Richard Riley, Charles Craddock, Lucinda Billingham Trials 2011, 12(Suppl 1):A16 (13 December 2011) |
|
Oral presentation
Designing a preliminary adaptive study to inform a biomarker trial in Psoriasis Andrew T Prevost, Jack Bowden Trials 2011, 12(Suppl 1):A17 (13 December 2011) |
|
Poster presentation
Javier Escudero, John P Zajicek, Emmanuel Ifeachor Trials 2011, 12(Suppl 1):A18 (13 December 2011) |
|
Poster presentation
Comparing diagnostic tests and biomarkers: trials in people with discordant test results Richard Hooper, Karla Díaz-Ordaz, Andrea Takeda, Khalid Khan Trials 2011, 12(Suppl 1):A19 (13 December 2011) |
|
Poster presentation
Choice of transformation for modelling non-linear continuous biomarkers Deborah D Stocken, Lucinda J Billingham, Philip J Johnson, Nick Freemantle Trials 2011, 12(Suppl 1):A20 (13 December 2011) |
